Zosano Pharma Stock Price - ZSAN

0.00
-0.7001 (-100.00%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Zosano Pharma Corporation ZSAN NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.00 0.0% 0.7001 0.00 0.00 0.00 0.7001 19:00:00
Bid Price Ask Price Spread Spread % News
0.67 0.72 0.05 6.94% - -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.00 USD

Zosano Pharma Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 17.39M 24.84M $ -35.36M -6.40 - 23.25M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Zosano Pharma News

Loading Messages....

Latest ZSAN Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ZSAN Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.790.80990.60360.73035372,288,296-0.0899-11.38%
1 Month1.201.220.5230.74623674,170,711-0.4999-41.66%
3 Months1.691.80340.5230.88309251,730,382-0.9899-58.57%
6 Months2.082.450.5231.05931,913-1.38-66.34%
1 Year5.115.900.5232.17754,583-4.41-86.3%
3 Years49.0058.200.52312.08838,587-48.30-98.57%
5 Years196.44240.000.52320.16650,803-195.74-99.64%

Zosano Pharma Description

Zosano Pharma Corp is a clinical-stage specialty pharmaceutical company. It has developed a transdermal microneedle patch system to deliver its formulations of existing drugs through the skin for the treatment of various indications. The company operates in one business segment which is developing human pharmaceutical products. All the business activity of the firm is functioned through the market of the United States. Its product includes Qtrypta (M207) which is a formulation of zolmitriptan delivered utilizing an Adhesive Dermally-Applied Microarray technology.


Your Recent History
NASDAQ
ZSAN
Zosano Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.